North America clinical nutrition market is expected to grow by 5.52% annually in the forecast period and reach $20.39 billion by 2026 driven by increasing incidence of malnutrition, the rising prevalence of communicable and non-communicable chronic diseases amid COVID-19 pandemic.
Highlighted with 28 tables and 66 figures, this 124-page report “North America Clinical Nutrition Market 2020-2026 by Substrate, Administration Route (Oral or Enteral, Parenteral), End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical nutrition market in every aspect of the classification from perspectives of Substrate, Administration Route, End User, Therapeutic Area, Healthcare Setting, Distribution Channel, and Country.
Based on Substrate, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Carbohydrates
• Lipids
• Proteins & Amino Acids
• Water & Electrolyte
• Dietary Fiber
• Antioxidants
• Other Substrates
Based on Administration Route, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
Oral or Enteral Administration
• Oral Nutrition Supplements
• Tube Feeding
Parenteral Administration
• Supplemental Parenteral Nutrition
• Total Parenteral Nutrition
• All-in-One System
• Multiple Bottle System
Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Infant
• Children
• Adult
• Geriatrics
Based on Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Cancer
• Neurology
• Renal Diseases
• Respiratory Diseases
• Other Therapeutic Areas
Based on Healthcare Setting, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Hospitals
• Long-term Care Facilities (LTC)
• Homecare
• Inpatient Rehabilitation Facilities
• Other Healthcare Settings
Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Institutional Sales
• Supermarkets & Hypermarkets
• Pharmacies
• Drug Stores
• Online Channels
• Other Distribution Channels
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each country, detailed analysis and data for annual revenue are available for 2019-2026. The breakdown of key national markets by Administration Route, End User, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America clinical nutrition market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestle Health Science
Nutricia Ltd
Perrigo Company Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Substrate 40
3.1 Market Overview by Substrate 40
3.2 Carbohydrates 42
3.3 Lipids 43
3.4 Proteins & Amino Acids 44
3.5 Water & Electrolyte 45
3.6 Dietary Fiber 46
3.7 Antioxidants 47
3.8 Other Substrates 48
4 Segmentation of North America Market by Administration Route 49
4.1 Market Overview by Administration Route 49
4.2 Oral or Enteral Administration 51
4.2.1 Oral Nutrition Supplements 53
4.2.2 Tube Feeding 54
4.3 Parenteral Administration 55
4.3.1 Supplemental Parenteral Nutrition 57
4.3.2 Total Parenteral Nutrition 58
4.3.3 All-in-One System 59
4.3.4 Multiple Bottle System 60
5 Segmentation of North America Market by End User 61
5.1 Market Overview by End User 61
5.2 Infant 63
5.3 Children 64
5.4 Adult 65
5.5 Geriatrics 66
6 Segmentation of North America Market by Therapeutic Area 67
6.1 Market Overview by Therapeutic Area 67
6.2 Malnutrition 69
6.3 Metabolic Disorders 70
6.4 Gastrointestinal Disorders 71
6.5 Cancer 72
6.6 Neurology 73
6.7 Renal Diseases 74
6.8 Respiratory Diseases 75
6.9 Other Therapeutic Areas 76
7 Segmentation of North America Market by Healthcare Setting 77
7.1 Market Overview by Healthcare Setting 77
7.2 Hospitals 79
7.3 Long-term Care Facilities (LTC) 80
7.4 Homecare 81
7.5 Inpatient Rehabilitation Facilities 82
7.6 Other Healthcare Settings 83
8 Segmentation of North America Market by Distribution Channel 84
8.1 Market Overview by Distribution Channel 84
8.2 Institutional Sales 86
8.3 Supermarkets & Hypermarkets 87
8.4 Pharmacies 88
8.5 Drug Stores 89
8.6 Online Channels 90
8.7 Other Distribution Channels 91
9 North America Market 2019-2026 by Country 92
9.1 Overview of North America Market 92
9.2 U.S. 95
9.3 Canada 99
9.4 Mexico 101
10 Competitive Landscape 103
10.1 Overview of Key Vendors 103
10.2 New Product Launch, Partnership, Investment, and M&A 106
10.3 Company Profiles 107
Abbott Nutrition 107
B Braun Melsungen Ag 109
BASF SE 110
Baxter International Inc. 111
Claris Lifesciences Ltd. 112
Fresenius Kabi Ag 113
Lonza Group AG 114
Nestle Health Science 115
Nutricia Ltd 116
Perrigo Company Plc 117
11 Investing in North America Market: Risk Assessment and Management 118
11.1 Risk Evaluation of North America Market 118
11.2 Critical Success Factors (CSFs) 121
Related Reports and Products 124
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Nutrition
B Braun Melsungen Ag
BASF SE
Baxter International Inc.
Claris Lifesciences Ltd.
Fresenius Kabi Ag
Lonza Group AG
Nestle Health Science
Nutricia Ltd
Perrigo Company Plc
Ěý
Ěý
*If Applicable.
